首页 > 最新文献

EMJ. Microbiology & infectious diseases最新文献

英文 中文
A Perfect Storm: COVID-19 and Antimicrobial Resistance. 完美风暴:COVID-19和抗菌素耐药性。
Pub Date : 2022-09-01 DOI: 10.33590/emjmicrobiolinfectdis/22-00082
Robert Redwood, Lucas T Schulz, Aurora Pop-Vicas, Michael S Pulia
For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, national, and global level. The years leading up to the COVID-19 pandemic were marked by important victories in the battle against AMR, including a surge in scientific inquiry on the topic, the development of multinational best practice consensus statements, the establishment of regional and global venues to share information, and a partially-funded commitment by world leaders to address the topic in a serious and sustained manner.
{"title":"A Perfect Storm: COVID-19 and Antimicrobial Resistance.","authors":"Robert Redwood, Lucas T Schulz, Aurora Pop-Vicas, Michael S Pulia","doi":"10.33590/emjmicrobiolinfectdis/22-00082","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/22-00082","url":null,"abstract":"For decades, infectious disease and public health experts have recognised antimicrobial resistance (AMR) and resulting infections due to multidrug resistant organisms as a persistent and increasingly urgent threat to public health at the local, national, and global level. The years leading up to the COVID-19 pandemic were marked by important victories in the battle against AMR, including a surge in scientific inquiry on the topic, the development of multinational best practice consensus statements, the establishment of regional and global venues to share information, and a partially-funded commitment by world leaders to address the topic in a serious and sustained manner.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":"2022 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828457/pdf/nihms-1850683.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10148187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspergillus terreus Peritonitis in a Child on Continuous Ambulatory Peritoneal Dialysis: A Case Report from Pakistan 持续动态腹膜透析的儿童发生土曲霉性腹膜炎:巴基斯坦1例报告
Pub Date : 2022-02-15 DOI: 10.33590/emjmicrobiolinfectdis/21-00243
Safia Moin, K. Moorani, H. Qureshi
Background: Aspergillus peritonitis is a rare, potentially fatal complication of continuous ambulatory peritoneal dialysis (CAPD). Several cases of fungal peritonitis (FP) caused by Aspergillus species have been reported worldwide; however, there is a paucity of data from Pakistan. Here, a case of congenital nephrotic syndrome is reported in a patient who progressed to Stage 5 chronic kidney disease when she was 8 years old, which was managed by CAPD and other supportive therapies. The patient developed FP and later succumbed to death despite appropriate management. Early diagnosis and careful interpretation of culture results are, therefore, important for the treatment of these patients.Case presentation: The patient outlined in this case report had congenital nephrotic syndrome, Stage 5 chronic kidney disease, and was on CAPD. She presented with peritonitis. Initially, broad spectrum antibiotics were started, and peritoneal samples did not yield any growth. Later, consecutive peritoneal samples taken from the patient grew Aspergillus terreus, with septate hyphae seen on a direct smear from the sample. Voriconazole was started immediately, and the patients’ catheter was removed. However, the patient’s condition deteriorated and, after prolonged intensive care and high ventilator support, the patient expired.Conclusion: A. terreus is an uncommon and deadly pathogen that does not respond to the commonly used antifungal treatments such as amphotericin B. The treatment of CAPD-related FP requires early diagnosis and the use of newer drugs such as voriconazole or caspofungin.
背景:曲霉性腹膜炎是一种罕见的、潜在致命的持续性非卧床腹膜透析并发症。由曲霉属引起的真菌性腹膜炎(FP)在世界范围内已有报道;然而,来自巴基斯坦的数据却很少。在这里,报告了一例先天性肾病综合征患者,她在8岁时发展为5期慢性肾病,通过CAPD和其他支持性疗法进行治疗。患者出现FP,尽管进行了适当的治疗,但最终还是死亡。因此,早期诊断和仔细解释培养结果对这些患者的治疗很重要。病例介绍:本病例报告中概述的患者患有先天性肾病综合征,5期慢性肾脏疾病,正在接受CAPD治疗。她表现为腹膜炎。最初,开始使用广谱抗生素,腹膜样本没有产生任何生长。后来,从患者身上连续采集的腹膜样本生长出土曲霉,在样本的直接涂片上可以看到有间隔的菌丝。立即开始使用伏立康唑,并取出患者的导管。然而,患者的病情恶化,经过长时间的重症监护和高强度的呼吸机支持,患者死亡。结论:A.terreus是一种罕见且致命的病原体,对常用的抗真菌治疗(如两性霉素B)没有反应。CAPD相关FP的治疗需要早期诊断并使用新的药物,如伏立康唑或卡泊芬净。
{"title":"Aspergillus terreus Peritonitis in a Child on Continuous Ambulatory Peritoneal Dialysis: A Case Report from Pakistan","authors":"Safia Moin, K. Moorani, H. Qureshi","doi":"10.33590/emjmicrobiolinfectdis/21-00243","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/21-00243","url":null,"abstract":"Background: Aspergillus peritonitis is a rare, potentially fatal complication of continuous ambulatory peritoneal dialysis (CAPD). Several cases of fungal peritonitis (FP) caused by Aspergillus species have been reported worldwide; however, there is a paucity of data from Pakistan. Here, a case of congenital nephrotic syndrome is reported in a patient who progressed to Stage 5 chronic kidney disease when she was 8 years old, which was managed by CAPD and other supportive therapies. The patient developed FP and later succumbed to death despite appropriate management. Early diagnosis and careful interpretation of culture results are, therefore, important for the treatment of these patients.\u0000\u0000Case presentation: The patient outlined in this case report had congenital nephrotic syndrome, Stage 5 chronic kidney disease, and was on CAPD. She presented with peritonitis. Initially, broad spectrum antibiotics were started, and peritoneal samples did not yield any growth. Later, consecutive peritoneal samples taken from the patient grew Aspergillus terreus, with septate hyphae seen on a direct smear from the sample. Voriconazole was started immediately, and the patients’ catheter was removed. However, the patient’s condition deteriorated and, after prolonged intensive care and high ventilator support, the patient expired.\u0000\u0000Conclusion: A. terreus is an uncommon and deadly pathogen that does not respond to the commonly used antifungal treatments such as amphotericin B. The treatment of CAPD-related FP requires early diagnosis and the use of newer drugs such as voriconazole or caspofungin.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48439016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in Infectious Diseases: A Retrospective 5-year Study 传染病趋势:一项5年回顾性研究
Pub Date : 2022-01-28 DOI: 10.33590/emjmicrobiolinfectdis/21.00056
Inês Rego de Figueiredo, J. Ferrão, S. Dias, R. Alves, A. Taulaigo, Mário Ferraz, S. Castro, A. M. Antunes, Cláudia Mihon, A. Lladó, Heidi Heidi Gruner, A. Panarra
Background: Although hospital admission is frequently due to the exacerbation of chronic diseases, most often it is caused by an underlying infectious process. Patients often have several admissions per year, making them at risk for recurrent infections, increased morbidity, and the emergence of resistant strains of microorganisms.Methods: This is a retrospective, descriptive study of all patients with an infectious disease diagnosis, who were admitted to the medical ward of a tertiary hospital during a 5-year period. Information was collected from electronic medical files regarding gender, age, autonomy, comorbidities, primary diagnosis, in-hospital length of stay, and mortality as well as microbiological data surveillance.Results: A total of 355 patients fulfilled the inclusion criteria. Amongst the sample analysed, the average age was 78.10±12.47 years. Of the patients, 57.2% (203) were female, with most patients considered as dependent according to Katz score. The average Charlson Comorbidity Index (CCI) score was 6.28±2.74, increasing with age. The main diagnostic categories were respiratory (191 patients: 137 with pneumonia and 49 with acute bronchitis) and urinary tract (138 patients: 69 with pyelonephritis and 66 with cystitis). Urinary tract infections were more frequent in females and in dependent patients. Only 37.8% of infections had a microbiologic isolate: Escherichia coli (28.4%), Pseudomonas aeruginosa (12.7%), and Klebsiella pneumoniae (8.2%). The overall mortality was 6.77%.Conclusions: The frequent in-hospital admission due to infectious diseases makes it imperative to characterise and follow-up on evolution of the disease itself in order to better know the characteristics of community-acquired diseases, establish routes of transmission and outbreak identification, microbiology patterns, and resistance towards further improving empiric therapy.
背景:尽管住院通常是由于慢性病的恶化,但最常见的是由潜在的传染过程引起的。患者通常每年有几次入院,这使他们面临反复感染、发病率增加和出现耐药性微生物菌株的风险。方法:这是一项回顾性的描述性研究,研究对象为五年内入住三级医院医疗病房的所有确诊为传染病的患者。从电子医疗档案中收集有关性别、年龄、自主性、合并症、初级诊断、住院时间、死亡率以及微生物数据监测的信息。结果:共有355名患者符合入选标准。在分析的样本中,平均年龄为78.10±12.47岁。在患者中,57.2%(203)为女性,根据Katz评分,大多数患者被视为依赖性患者。Charlson合并症指数(CCI)的平均得分为6.28±2.74,随年龄增长而增加。主要诊断类别为呼吸道(191例患者:137例肺炎和49例急性支气管炎)和泌尿道(138例患者:69例肾盂肾炎和66例膀胱炎)。尿路感染在女性和依赖性患者中更为常见。只有37.8%的感染者具有微生物分离物:大肠杆菌(28.4%)、铜绿假单胞菌(12.7%)、,和肺炎克雷伯菌(8.2%)。总死亡率为6.77%,以及对进一步改进经验性治疗的抵制。
{"title":"Trends in Infectious Diseases: A Retrospective 5-year Study","authors":"Inês Rego de Figueiredo, J. Ferrão, S. Dias, R. Alves, A. Taulaigo, Mário Ferraz, S. Castro, A. M. Antunes, Cláudia Mihon, A. Lladó, Heidi Heidi Gruner, A. Panarra","doi":"10.33590/emjmicrobiolinfectdis/21.00056","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/21.00056","url":null,"abstract":"Background: Although hospital admission is frequently due to the exacerbation of chronic diseases, most often it is caused by an underlying infectious process. Patients often have several admissions per year, making them at risk for recurrent infections, increased morbidity, and the emergence of resistant strains of microorganisms.\u0000\u0000Methods: This is a retrospective, descriptive study of all patients with an infectious disease diagnosis, who were admitted to the medical ward of a tertiary hospital during a 5-year period. Information was collected from electronic medical files regarding gender, age, autonomy, comorbidities, primary diagnosis, in-hospital length of stay, and mortality as well as microbiological data surveillance.\u0000\u0000Results: A total of 355 patients fulfilled the inclusion criteria. Amongst the sample analysed, the average age was 78.10±12.47 years. Of the patients, 57.2% (203) were female, with most patients considered as dependent according to Katz score. The average Charlson Comorbidity Index (CCI) score was 6.28±2.74, increasing with age. The main diagnostic categories were respiratory (191 patients: 137 with pneumonia and 49 with acute bronchitis) and urinary tract (138 patients: 69 with pyelonephritis and 66 with cystitis). Urinary tract infections were more frequent in females and in dependent patients. Only 37.8% of infections had a microbiologic isolate: Escherichia coli (28.4%), Pseudomonas aeruginosa (12.7%), and Klebsiella pneumoniae (8.2%). The overall mortality was 6.77%.\u0000\u0000Conclusions: The frequent in-hospital admission due to infectious diseases makes it imperative to characterise and follow-up on evolution of the disease itself in order to better know the characteristics of community-acquired diseases, establish routes of transmission and outbreak identification, microbiology patterns, and resistance towards further improving empiric therapy.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45261719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aviptadil: Class Effect of a Synthetic Vasoactive Intestinal Peptide as a Treatment Option in Patients with COVID-19 with Severe Respiratory Failure 阿维他地尔:一种合成血管活性肠肽在COVID-19合并严重呼吸衰竭患者中的治疗效果
Pub Date : 2022-01-10 DOI: 10.33590/emjmicrobiolinfectdis/21-00222
D. Chakraborty, Shouvik Choudhury, S. Lahiry
Despite dynamic drug and vaccine development processes to reduce the disease burden of COVID-19, the treatment options are still very limited. Vasoactive intestinal peptide (VIP) has a diversified physiological action with specific features of lung protection-related activities.VIP inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gene replication in human monocytes and the viral replication in Calu-3 cells, thus further reducing the generation of proinflammatory mediators. Aviptadil, a synthetic form of VIP, is the only pulmonary therapeutic agent to have been granted ‘fast track’ status by the U.S. Food and Drug Administration (FDA) and to be allowed into both Phase II and III clinical trials. Initial binding of Aviptadil with non-structural protein (nsp) 10 and nsp16, which may inhibit the 2’-O-methyltransferase activity of the SARS-CoV-2 nsp10 and nsp16 complex.Aviptadil has already proved to be an effective option in the treatment of severe respiratory failures due to sepsis and other related lung injuries. Interim analysis results of this drug used in respiratory failure caused by SARS-CoV-2 has evolved a new hope in regard to safety and efficacy. The final results from a recently completed trial, as well as all currently ongoing trials, will clarify the class effect of this drug in the treatment of COVID-19 in future days.
尽管有动态的药物和疫苗开发进程,以减轻COVID-19的疾病负担,但治疗选择仍然非常有限。血管活性肠肽(Vasoactive intestinal peptide, VIP)具有多种生理作用,具有特定的肺保护功能。VIP可抑制人单核细胞中的SARS-CoV-2基因复制和Calu-3细胞中的病毒复制,从而进一步减少促炎介质的产生。Aviptadil是维普的一种合成形式,是唯一一种被美国食品和药物管理局(FDA)授予“快速通道”地位的肺部治疗药物,并被允许进入II期和III期临床试验。阿维他尔与非结构蛋白(nsp) 10和nsp16的初始结合,可能抑制SARS-CoV-2 nsp10和nsp16复合物的2 ' - o -甲基转移酶活性。阿维他地尔已经被证明是治疗因败血症和其他相关肺损伤引起的严重呼吸衰竭的有效选择。该药物用于SARS-CoV-2呼吸衰竭的中期分析结果,在安全性和有效性方面产生了新的希望。最近完成的一项试验以及目前正在进行的所有试验的最终结果将在未来几天阐明这种药物在治疗COVID-19中的类别效果。
{"title":"Aviptadil: Class Effect of a Synthetic Vasoactive Intestinal Peptide as a Treatment Option in Patients with COVID-19 with Severe Respiratory Failure","authors":"D. Chakraborty, Shouvik Choudhury, S. Lahiry","doi":"10.33590/emjmicrobiolinfectdis/21-00222","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/21-00222","url":null,"abstract":"Despite dynamic drug and vaccine development processes to reduce the disease burden of COVID-19, the treatment options are still very limited. Vasoactive intestinal peptide (VIP) has a diversified physiological action with specific features of lung protection-related activities.\u0000\u0000VIP inhibits severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) gene replication in human monocytes and the viral replication in Calu-3 cells, thus further reducing the generation of proinflammatory mediators. Aviptadil, a synthetic form of VIP, is the only pulmonary therapeutic agent to have been granted ‘fast track’ status by the U.S. Food and Drug Administration (FDA) and to be allowed into both Phase II and III clinical trials. Initial binding of Aviptadil with non-structural protein (nsp) 10 and nsp16, which may inhibit the 2’-O-methyltransferase activity of the SARS-CoV-2 nsp10 and nsp16 complex.\u0000\u0000Aviptadil has already proved to be an effective option in the treatment of severe respiratory failures due to sepsis and other related lung injuries. Interim analysis results of this drug used in respiratory failure caused by SARS-CoV-2 has evolved a new hope in regard to safety and efficacy. The final results from a recently completed trial, as well as all currently ongoing trials, will clarify the class effect of this drug in the treatment of COVID-19 in future days.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47320309","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The PPE Pandemic: Sex-Related Discrepancies of N95 Mask Fit 个人防护用品大流行病:N95口罩佩戴的性别差异
Pub Date : 2021-08-19 DOI: 10.33590/emjmicrobiolinfectdis/20-00215
Laura Christopher, T. Rohr-Kirchgraber, Saralyn Mark
During the COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2, healthcare professionals across the world have been at high risk of transmission because of their direct contact with infected patients. In October 2020, the International Council of Nurses (ICN) confirmed that 1,500 nurses had died from COVID-19 in 44 countries and estimated that healthcare worker COVID-19 fatalities worldwide could be more than 20,000. To ensure protection of healthcare personnel, properly fitting personal protective equipment (PPE) must be worn. In a ‘one size fits all’ world, the differences between the fit of PPE for men and women can have devastating consequences. An N95 respirator mask is a component of PPE outlined by the Centers for Disease Control and Prevention (CDC) for protection against COVID-19; however, N95 masks do not offer protection if they do not fit properly. Fit testing is performed to ensure an adequate seal of the mask on the wearer. A single-institution retrospective review was performed on fit testing results for male versus female wearers in an attempt to elucidate a difference in failure rates. Females failed at a significantly higher rate than their male counterparts (6.67% female, 2.72% male; p=0.001), and the reason reported was often due to being ‘small-boned’ (p<0.0001). Sex-related differences in proper PPE fit are not new; however, the COVID-19 pandemic has made the situation more acute, and sex-specific N95 mask designs must be developed quickly, as the pandemic shows little signs of abating.
在由严重急性呼吸系统综合征冠状病毒2引起的COVID-19大流行期间,世界各地的卫生保健专业人员因直接接触受感染患者而处于传播的高风险之中。2020年10月,国际护士理事会(ICN)证实,44个国家有1500名护士死于COVID-19,并估计全球COVID-19医护人员死亡人数可能超过2万人。为确保医护人员得到保护,必须穿戴合适的个人防护装备(PPE)。在一个“一刀切”的世界里,男性和女性个人防护装备适合度的差异可能会造成毁灭性的后果。N95口罩是美国疾病控制与预防中心(CDC)为预防COVID-19而概述的个人防护装备的一个组成部分;然而,如果N95口罩不合适,就不能提供保护。进行贴合测试以确保口罩在佩戴者身上有足够的密封性。对男性和女性佩戴者的适合性测试结果进行了单机构回顾性审查,试图阐明失败率的差异。女性不合格率显著高于男性(女性6.67%,男性2.72%;P =0.001),报告的原因通常是由于“骨小”(P <0.0001)。与性别有关的个人防护装备是否合适的差异并不新鲜;然而,COVID-19大流行使情况更加严重,必须迅速开发针对性别的N95口罩设计,因为大流行几乎没有减弱的迹象。
{"title":"The PPE Pandemic: Sex-Related Discrepancies of N95 Mask Fit","authors":"Laura Christopher, T. Rohr-Kirchgraber, Saralyn Mark","doi":"10.33590/emjmicrobiolinfectdis/20-00215","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/20-00215","url":null,"abstract":"During the COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2, healthcare professionals across the world have been at high risk of transmission because of their direct contact with infected patients. In October 2020, the International Council of Nurses (ICN) confirmed that 1,500 nurses had died from COVID-19 in 44 countries and estimated that healthcare worker COVID-19 fatalities worldwide could be more than 20,000. To ensure protection of healthcare personnel, properly fitting personal protective equipment (PPE) must be worn. In a ‘one size fits all’ world, the differences between the fit of PPE for men and women can have devastating consequences. An N95 respirator mask is a component of PPE outlined by the Centers for Disease Control and Prevention (CDC) for protection against COVID-19; however, N95 masks do not offer protection if they do not fit properly. Fit testing is performed to ensure an adequate seal of the mask on the wearer. A single-institution retrospective review was performed on fit testing results for male versus female wearers in an attempt to elucidate a difference in failure rates. Females failed at a significantly higher rate than their male counterparts (6.67% female, 2.72% male; p=0.001), and the reason reported was often due to being ‘small-boned’ (p<0.0001). Sex-related differences in proper PPE fit are not new; however, the COVID-19 pandemic has made the situation more acute, and sex-specific N95 mask designs must be developed quickly, as the pandemic shows little signs of abating.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46854665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient 免疫正常患者肩胛间区皮肤毛霉病
Pub Date : 2021-08-19 DOI: 10.33590/emjmicrobiolinfectdis/20-00243
Pankil Doshi, Yash Sanghvi, J. Doctor, Vaibhavi Parsaniya
Mucormycosis is an invasive fungal infection caused by opportunistic fungi of the phylum Glomeromycotan, subphylum Mucormycotina, mainly affecting individuals with immunosuppression. Cutaneous mucormycosis is the third most common clinical form of the disease preceded by pulmonary and rhinocerebral mucormycosis. The usual factors predisposing to this infection are individuals who are immunocompromised with conditions like HIV, haematological malignancies, and diabetes mellitus, but a significant proportion of patients are immunocompetent. The agents of mucormycosis are abundantly present in nature and are transmitted to the skin by direct inoculation. It may be due to needle sticks, stings, and bites by animals, motor-vehicle accidents, natural disasters, and burn injuries. The clinical presentation is non-specific, but an indurated plaque that rapidly evolves to necrosis (eschar) is a common finding. The infection can invade locally, and also penetrate into the adjacent fat, muscle, fascia, and bone, or become disseminated. It is difficult to diagnose because of the non-specific presentation of mucormycosis. Biopsy and culture should be performed. Treatment consists of multidisciplinary management, including surgical debridement, use of antifungal drugs (amphotericin B and posaconazole), and reversal of underlying risk factors, when possible. Mortality rates are significant, ranging from 4% to 10% in localised mucormycosis infection, but are lower than the other forms of the disease. The authors present a case here of a 38-year-old immunocompetent male with cutaneous mucormycosis at the interscapular region.
毛霉菌病是一种侵袭性真菌感染,由毛霉菌门毛霉菌亚门的机会性真菌引起,主要影响免疫抑制个体。皮肤毛霉菌病是该疾病的第三种最常见的临床形式,仅次于肺和鼻脑毛霉菌病。导致这种感染的常见因素是患有HIV、血液系统恶性肿瘤和糖尿病等免疫功能低下的患者,但有很大一部分患者具有免疫功能。毛霉菌病的病原体在自然界中大量存在,并通过直接接种传播到皮肤。这可能是由于针刺、动物蜇伤、机动车事故、自然灾害和烧伤。临床表现是非特异性的,但硬结斑块迅速发展为坏死(焦痂)是一种常见的发现。感染可以局部侵袭,也可以渗透到邻近的脂肪、肌肉、筋膜和骨骼,或变得播散。由于毛霉菌病的非特异性表现,很难诊断。应进行活检和培养。治疗包括多学科管理,包括手术清创,使用抗真菌药物(两性霉素B和泊沙康唑),并在可能的情况下逆转潜在的风险因素。局部毛霉菌病感染的死亡率很高,从4%到10%不等,但低于其他形式的疾病。作者报告了一例38岁的免疫功能正常男性,其肩胛间皮肤毛霉菌病。
{"title":"Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient","authors":"Pankil Doshi, Yash Sanghvi, J. Doctor, Vaibhavi Parsaniya","doi":"10.33590/emjmicrobiolinfectdis/20-00243","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/20-00243","url":null,"abstract":"Mucormycosis is an invasive fungal infection caused by opportunistic fungi of the phylum Glomeromycotan, subphylum Mucormycotina, mainly affecting individuals with immunosuppression. Cutaneous mucormycosis is the third most common clinical form of the disease preceded by pulmonary and rhinocerebral mucormycosis. The usual factors predisposing to this infection are individuals who are immunocompromised with conditions like HIV, haematological malignancies, and diabetes mellitus, but a significant proportion of patients are immunocompetent. The agents of mucormycosis are abundantly present in nature and are transmitted to the skin by direct inoculation. It may be due to needle sticks, stings, and bites by animals, motor-vehicle accidents, natural disasters, and burn injuries. The clinical presentation is non-specific, but an indurated plaque that rapidly evolves to necrosis (eschar) is a common finding. The infection can invade locally, and also penetrate into the adjacent fat, muscle, fascia, and bone, or become disseminated. It is difficult to diagnose because of the non-specific presentation of mucormycosis. Biopsy and culture should be performed. Treatment consists of multidisciplinary management, including surgical debridement, use of antifungal drugs (amphotericin B and posaconazole), and reversal of underlying risk factors, when possible. Mortality rates are significant, ranging from 4% to 10% in localised mucormycosis infection, but are lower than the other forms of the disease. The authors present a case here of a 38-year-old immunocompetent male with cutaneous mucormycosis at the interscapular region.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44026209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications and Aspects of Lyme Neuroborreliosis 莱姆病神经螺旋体病的意义和方面
Pub Date : 2021-08-19 DOI: 10.33590/emjmicrobiolinfectdis/21-00001
Cody Riggle, C. Brissette
Lyme borreliosis or Lyme disease affects thousands of people globally each year, and, with nervous system involvement, this disease can lead to the development of Lyme neuroborreliosis (LNB). If not diagnosed and treated properly, LNB can lead to serious life-long health implications for affected patients. The clinical manifestations and treatment regimens are relatively well-studied, but much remains unknown about the disease’s pathogenesis and epidemiology. In this review, the authors elucidate the knowns and unknowns of LNB.
莱姆病或莱姆病每年影响全球数千人,并且随着神经系统的受累,这种疾病可导致莱姆病神经螺旋体病(LNB)的发展。如果诊断和治疗不当,LNB可能对受影响的患者造成严重的终身健康影响。临床表现和治疗方案的研究相对较好,但对该病的发病机制和流行病学仍知之甚少。在这篇综述中,作者阐明了LNB的已知和未知。
{"title":"Implications and Aspects of Lyme Neuroborreliosis","authors":"Cody Riggle, C. Brissette","doi":"10.33590/emjmicrobiolinfectdis/21-00001","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/21-00001","url":null,"abstract":"Lyme borreliosis or Lyme disease affects thousands of people globally each year, and, with nervous system involvement, this disease can lead to the development of Lyme neuroborreliosis (LNB). If not diagnosed and treated properly, LNB can lead to serious life-long health implications for affected patients. The clinical manifestations and treatment regimens are relatively well-studied, but much remains unknown about the disease’s pathogenesis and epidemiology. In this review, the authors elucidate the knowns and unknowns of LNB.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47231873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disseminated Phaeohyphomycotic Lymphadenitis with Cladophialophora Species 具有分支体的播散性黄球霉菌性淋巴结炎
Pub Date : 2021-07-19 DOI: 10.33590/EMJMICROBIOLINFECTDIS/20-00276
Safia Moin, F. Mahmood, J. Farooqi, Faheem Naqvi, Romana Idress, K. Jabeen, A. Zafar
Objective: This study describes a case of disseminated phaeohyphomycotic lymphadenitis in a young female with delayed diagnosis and good clinical response after appropriate treatment. Methods: A 32-year-old female presented with erythematous to violaceous papules with oozing discharge bilaterally in her inguinal region for a few months. History revealed tuberculous meningitis 4 years earlier treated with first line anti-tuberculous therapy for 18 months, and 2 years previously she developed pigmented discharging lymph nodes bilaterally in her axillae. The histopathology of the biopsy of the axillary nodes showed chronic granulomatous inflammation with multiple branching septate fungal hyphae. She received amphotericin B for 21 days but without improvement. Biopsy from the inguinal lesions was sent for histopathology and culture. Results: Histopathology of the biopsy material showed chronic granulomatous inflammatory process with multinucleate giant cells, epithelioid cells, histiocytes, and lymphocytes with multiple branching septate fungal hyphae. Gram stain revealed moderate septate hyphae with numerous pus cells. Culture on Sabouraud dextrose agar yielded velvety olive–black colonies in the fourth week. Microscopic slide examination of culture material was suggestive of Cladophialophora species. The patient was started on voriconazole, which was continued for 6 months, and showed clinical improvement.Conclusion: Incomplete investigation of infectious lesions may delay diagnosis. Furthermore, clinical presentations are greatly influenced by the immune status of the host. Both histopathological and microbiological assessments are equally important for making a conclusive diagnosis. Anti-fungal therapy may delay the growth of fungi that normally grow within a week; thus, a longer incubation time may be warranted for fungal smear-positive samples.
目的:本研究描述一例年轻女性播散性黄细胞性淋巴结炎,诊断延迟,经适当治疗后临床反应良好。方法:一位32岁的女性,其腹股沟区出现红斑至紫罗兰色丘疹,并伴有双侧渗出物,持续数月。病史显示,结核性脑膜炎4年前接受了18个月的一线抗结核治疗,2年前她腋窝两侧出现色素性淋巴结排出。腋窝淋巴结活检的组织病理学表现为慢性肉芽肿性炎症,伴有多分支分隔真菌菌丝。她接受两性霉素B治疗21天,但没有好转。腹股沟病变的活检被送去进行组织病理学和培养。结果:活检材料的组织病理学显示慢性肉芽肿性炎症过程,有多核巨细胞、上皮样细胞、组织细胞和淋巴细胞,并有多分支分隔真菌菌丝。革兰氏染色显示中等间隔的菌丝和大量的脓细胞。在沙氏葡萄糖琼脂上培养第四周产生天鹅绒般的橄榄黑色菌落。培养材料的显微镜载玻片检查提示了枝藻属物种。患者开始服用伏立康唑,持续服用6个月,临床症状有所改善。结论:对感染性病变的调查不全面可能延误诊断。此外,临床表现在很大程度上受宿主免疫状态的影响。组织病理学和微生物学评估对于做出结论性诊断同样重要。抗真菌治疗可能会延迟正常生长的真菌在一周内的生长;因此,真菌涂片阳性样本可能需要更长的培养时间。
{"title":"Disseminated Phaeohyphomycotic Lymphadenitis with Cladophialophora Species","authors":"Safia Moin, F. Mahmood, J. Farooqi, Faheem Naqvi, Romana Idress, K. Jabeen, A. Zafar","doi":"10.33590/EMJMICROBIOLINFECTDIS/20-00276","DOIUrl":"https://doi.org/10.33590/EMJMICROBIOLINFECTDIS/20-00276","url":null,"abstract":"Objective: This study describes a case of disseminated phaeohyphomycotic lymphadenitis in a young female with delayed diagnosis and good clinical response after appropriate treatment. \u0000Methods: A 32-year-old female presented with erythematous to violaceous papules with oozing discharge bilaterally in her inguinal region for a few months. History revealed tuberculous meningitis 4 years earlier treated with first line anti-tuberculous therapy for 18 months, and 2 years previously she developed pigmented discharging lymph nodes bilaterally in her axillae. The histopathology of the biopsy of the axillary nodes showed chronic granulomatous inflammation with multiple branching septate fungal hyphae. She received amphotericin B for 21 days but without improvement. Biopsy from the inguinal lesions was sent for histopathology and culture. \u0000Results: Histopathology of the biopsy material showed chronic granulomatous inflammatory process with multinucleate giant cells, epithelioid cells, histiocytes, and lymphocytes with multiple branching septate fungal hyphae. Gram stain revealed moderate septate hyphae with numerous pus cells. Culture on Sabouraud dextrose agar yielded velvety olive–black colonies in the fourth week. Microscopic slide examination of culture material was suggestive of Cladophialophora species. The patient was started on voriconazole, which was continued for 6 months, and showed clinical improvement.\u0000Conclusion: Incomplete investigation of infectious lesions may delay diagnosis. Furthermore, clinical presentations are greatly influenced by the immune status of the host. Both histopathological and microbiological assessments are equally important for making a conclusive diagnosis. Anti-fungal therapy may delay the growth of fungi that normally grow within a week; thus, a longer incubation time may be warranted for fungal smear-positive samples.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49189833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indoor Microbiome and The Rising Asthma Prevalence 室内微生物群与哮喘患病率上升
Pub Date : 2020-06-01 DOI: 10.33590/microbiolinfectdis/19-00190
Xi Fu, Yu Sun
The prevalence of asthma has increased in the past few decades in most developed and developing countries. Large-scale, cross-sectional epidemiological studies have reported several factors associated with asthma prevalence and severity, including parental asthma, tobacco smoking, preterm delivery, virus infection, and air pollution. However, a puzzling problem is that the time trends in the prevalence of these risk factors cannot explain the rise in asthma. For example, the prevalence of smoking and clinical pneumonia have been decreasing globally in the past few decades. Recent progress in high-throughput sequencing technology has promoted the progress of microbiome research and established associations between human and indoor microbiomes, and many metabolic, cognitive, and immune diseases including asthma and allergies. In this review, the authors systematically summarise the current literature, standard practice, and analysis pipeline in the field of indoor microbiome and asthma. The strength and limitation of different analytical approaches are discussed, including the utilisation of relative and absolute abundance in the associated studies. The authors discuss new frameworks of integrated microbiome research from different ecological niches, functional profiling from multiomics data, and how these new insights can facilitate understanding of asthma mechanisms and even the development of new personalised treatment strategies for the rising asthma epidemic.
在过去几十年中,大多数发达国家和发展中国家的哮喘患病率有所增加。大规模、横断面流行病学研究报告了与哮喘患病率和严重程度相关的几个因素,包括父母哮喘、吸烟、早产、病毒感染和空气污染。然而,一个令人困惑的问题是,这些危险因素流行的时间趋势并不能解释哮喘发病率的上升。例如,在过去几十年中,全球吸烟和临床肺炎的患病率一直在下降。高通量测序技术的最新进展促进了微生物组研究的进展,并建立了人体和室内微生物组与许多代谢、认知和免疫疾病(包括哮喘和过敏)之间的联系。本文系统综述了室内微生物组与哮喘的相关文献、标准实践和分析进展。讨论了不同分析方法的强度和局限性,包括在相关研究中相对丰度和绝对丰度的利用。作者讨论了来自不同生态位的综合微生物组研究的新框架,来自多组学数据的功能分析,以及这些新见解如何促进对哮喘机制的理解,甚至为不断上升的哮喘流行制定新的个性化治疗策略。
{"title":"Indoor Microbiome and The Rising Asthma Prevalence","authors":"Xi Fu, Yu Sun","doi":"10.33590/microbiolinfectdis/19-00190","DOIUrl":"https://doi.org/10.33590/microbiolinfectdis/19-00190","url":null,"abstract":"The prevalence of asthma has increased in the past few decades in most developed and developing countries. Large-scale, cross-sectional epidemiological studies have reported several factors associated with asthma prevalence and severity, including parental asthma, tobacco smoking, preterm delivery, virus infection, and air pollution. However, a puzzling problem is that the time trends in the prevalence of these risk factors cannot explain the rise in asthma. For example, the prevalence of smoking and clinical pneumonia have been decreasing globally in the past few decades. Recent progress in high-throughput sequencing technology has promoted the progress of microbiome research and established associations between human and indoor microbiomes, and many metabolic, cognitive, and immune diseases including asthma and allergies. In this review, the authors systematically summarise the current literature, standard practice, and analysis pipeline in the field of indoor microbiome and asthma. The strength and limitation of different analytical approaches are discussed, including the utilisation of relative and absolute abundance in the associated studies. The authors discuss new frameworks of integrated microbiome research from different ecological niches, functional profiling from multiomics data, and how these new insights can facilitate understanding of asthma mechanisms and even the development of new personalised treatment strategies for the rising asthma epidemic.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69455752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel Disorders 胃肠道炎症和肠道微生物组:一个对炎症性肠病诊断和治疗有意义的进化概念框架
Pub Date : 2020-06-01 DOI: 10.33590/emjmicrobiolinfectdis/20-00050
O. Grundmann
The human gut microbiome has garnered much attention over the past two decades with important discoveries linking it to human health and disease. The commensal bacterial flora evolves due to the influence of a number of factors including diet, pathogen exposure, environmental toxicants, disease states, and a challenged microenvironment that requires balancing with the host itself. However, the composition of bacterial species can impact and contribute to the development of local and systemic inflammation. Among the factors attributed to intestinal inflammation are dysbiosis caused by pathogenic bacteria, following decreased host immunity or loss of intestinal barrier function. Dysbiosis can also be triggered by antibiotic therapy or the use of other medications that allow for colonisation of pathogenic bacteria, such as proton pump inhibitors. The imbalance with commensal bacteria leads to the generation of proinflammatory mediators and a reduction of host immune defences, due to a lack of short-chain fatty acid generation needed for energy production to maintain barrier and immune function. The initially localised inflammation results in further dysbiosis as former commensal bacteria are able to breach the barrier and cause systemic immune responses. Low-grade systemic inflammation is a hallmark of inflammatory bowel disease. Because a specific dysbiosis is common in patients with inflammatory bowel disease, it can serve as an early diagnostic marker in its development. Furthermore, faecal microbiome transplants have shown promising benefits in patients with ulcerative colitis and Crohn’s disease.
在过去的二十年里,人类肠道微生物组引起了人们的广泛关注,重要发现将其与人类健康和疾病联系起来。共生菌群的进化受到许多因素的影响,包括饮食、病原体暴露、环境毒物、疾病状态以及需要与宿主自身平衡的挑战性微环境。然而,细菌种类的组成会影响并促进局部和全身炎症的发展。肠道炎症的因素包括病原菌引起的生态失调,宿主免疫力下降或肠道屏障功能丧失。抗生素治疗或使用其他允许病原菌定植的药物(如质子泵抑制剂)也可能引发生物失调。由于缺乏维持屏障和免疫功能所需的能量产生所需的短链脂肪酸,与共生细菌的失衡导致促炎介质的产生和宿主免疫防御的减少。最初的局部炎症会导致进一步的生态失调,因为以前的共生细菌能够突破屏障并引起系统免疫反应。低度系统性炎症是炎症性肠病的标志。由于特定的微生态失调在炎症性肠病患者中很常见,它可以作为其发展的早期诊断标志。此外,粪便微生物组移植对溃疡性结肠炎和克罗恩病患者显示出良好的疗效。
{"title":"Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel Disorders","authors":"O. Grundmann","doi":"10.33590/emjmicrobiolinfectdis/20-00050","DOIUrl":"https://doi.org/10.33590/emjmicrobiolinfectdis/20-00050","url":null,"abstract":"The human gut microbiome has garnered much attention over the past two decades with important discoveries linking it to human health and disease. The commensal bacterial flora evolves due to the influence of a number of factors including diet, pathogen exposure, environmental toxicants, disease states, and a challenged microenvironment that requires balancing with the host itself. However, the composition of bacterial species can impact and contribute to the development of local and systemic inflammation. Among the factors attributed to intestinal inflammation are dysbiosis caused by pathogenic bacteria, following decreased host immunity or loss of intestinal barrier function. Dysbiosis can also be triggered by antibiotic therapy or the use of other medications that allow for colonisation of pathogenic bacteria, such as proton pump inhibitors. The imbalance with commensal bacteria leads to the generation of proinflammatory mediators and a reduction of host immune defences, due to a lack of short-chain fatty acid generation needed for energy production to maintain barrier and immune function. The initially localised inflammation results in further dysbiosis as former commensal bacteria are able to breach the barrier and cause systemic immune responses. Low-grade systemic inflammation is a hallmark of inflammatory bowel disease. Because a specific dysbiosis is common in patients with inflammatory bowel disease, it can serve as an early diagnostic marker in its development. Furthermore, faecal microbiome transplants have shown promising benefits in patients with ulcerative colitis and Crohn’s disease.","PeriodicalId":72900,"journal":{"name":"EMJ. Microbiology & infectious diseases","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49033072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
EMJ. Microbiology & infectious diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1